Skip to content

Jeny Zarmon

Senior Attorney

Jeny Zarmon brings a strong command of U.S. securities law, advising domestic issuers and foreign private issuers across a broad spectrum of securities and capital markets matters. Her practice focuses on public company advisory, pre-IPO readiness, and capital markets representation, with particular experience guiding companies through SEC reporting and disclosure obligations, corporate governance, exchange compliance, and capital markets transactions, including initial public offerings, follow-on offerings, at-the-market programs, reverse mergers, and other registered and exempt securities offerings.

In her public company practice, Jeny supports boards of directors, management teams, and investors on corporate governance, exchange listing requirements, and securities compliance. She advises public companies and companies preparing to enter the public markets on the legal and practical demands of operating as a public company, including periodic and current reporting obligations under the Securities Exchange Act of 1934, disclosure controls and procedures, insider trading policies, board and committee governance, and exchange listing standards. She has extensive experience preparing and reviewing periodic reports, proxy statements, and shareholder communications, and provides practical counsel on market disclosure strategy. Her ability to guide clients through both routine and transformational matters makes her a trusted advisor to companies accessing and operating in the U.S. capital markets.

Jeny regularly represents clients in connection with a wide range of securities offerings and capital formation transactions, including registered offerings under the Securities Act of 1933 and exempt offerings of debt and equity securities under Regulation A+, Regulation S, Rule 506 of Regulation D, and Rule 144A. Her experience includes advising on Securities Act registration and exemption issues, disclosure considerations, and transaction execution across domestic and cross-border matters. Jeny also maintains an active private company practice, advising emerging and established businesses on capital formation, corporate structuring, and strategic growth initiatives. She works closely with private companies as they prepare for liquidity events or entry into public markets, helping them establish governance frameworks, develop disclosure practices, and position themselves for successful transactions.

With a strong foundation in both transactional and securities matters, Jeny provides integrated, business-focused counsel on mergers and acquisitions, financing transactions, and other strategic corporate matters. Her combined experience in domestic and cross-border transactions enables her to help clients effectively access U.S. markets and meet the expectations of global investors at every stage of growth.

Education

J.D., cum laude, Seton Hall University School of Law
B.A., magna cum laude, Northeastern University

Languages

English, Russian

State Bar Licenses

New York, New Jersey, Florida

Court Admissions

U.S. District Ct., District of New Jersey
U.S. District Ct., S.D. of New York
U.S. District Ct., E.D. of New York
  • Advised HCW Biologics, a clinical-state biopharmaceutical company, in $4 million pipe offering.
  • Advised Perpetual Markets Ltd., a financial technology company, in $87 million cross-border acquisition by NASDAQ-listed company.
  • Represented investor in connection with private fund/SPV investments in vehicles holding interests in xAI and SpaceX.
  • Issuer counsel to a wave energy company in a $3 million public ADS/warrant offering.
  • Issuer counsel to a NASDAQ-listed UAE-based mobility tech provider in a $4.7 million private placement.
  • Issuer counsel to NYSE-listed satellite communications company in a $7.1 million ATM offering.
  • Issuer counsel to clinical-stage pharma company in $100 million and $75 million ATM programs.
  • Issuer counsel to placenta-based biotech in $10 million ATM and $8.2 million PIPE.
  • Issuer counsel to late-stage biopharma company in $14 million and $16.2 million private placements.
  • Issuer counsel to manufacturer and developer of ruggedized tactical communication headset devices in connection with its $5 million IPO on NYSE American.
  • Issuer counsel to NASDAQ-listed clean energy company in $4 million public offering, $2.5 million private placement, $9.35 million ATM, and $15 million uplisting/private rounds.
  • Issuer counsel to NASDAQ-listed medical device company in $3.4 million registered direct and $3.9 million public offering.
  • Issuer counsel to NASDAQ-listed medical technology company in $9.7 million ATM, and $14.5 million and $17 million public offerings.
  • Issuer counsel to a computational biology company in $8.5 million public offering.
  • Issuer counsel to telehealth/remote monitoring company in $12 million public offering.
  • Issuer counsel to AI wearables company in $16 million IPO on NASDAQ.
  • Underwriter counsel in $10 million public offering of shared by a global PCB solutions company.
  • Placement agent counsel on multiple equity financings for U.S. and foreign private issuers from Canada, Cayman Islands, and Israel.
  • Counsel to NASDAQ-listed 3D electronics company in proposed hostile partial tender offer and in acquisition of high-performance electronics and software provider.

The Clark Hill approach is equally pragmatic and growth-minded, which is why we understand our clients’ toughest business challenges. Our multidisciplinary, global team of advisors focuses on smart legal solutions, delivered simply.

© 2026 Clark Hill PLC.